TheBullseye

Moderna $MRNA

看多
NASDAQ:MRNA   Moderna, Inc.
Moderna is one of the best pick for COVID-19 vaccine. They have already started dosing patients and expect the vaccine to be available for high-risk people like healthcare workers in the Fall this year.
The strength is rising and needs to close above $36 by the end of next week.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。